Alchemy Pharmatech is an innovation-driven company developing drug delivery platforms in partnership with the pharmaceutical industry.
Reflecting the company’s focus on developing unique products to meet healthcare needs, we have technology platforms to aerosolise dry powder medicines for intranasal delivery.
The unique design confers high patient compliance and the elimination of inter-operator variability. Such devices are compact and price-competitive.
Systemic drugs are delivered to the mid-nasal passages and cross into the bloodstream for rapid onset. Protiens, peptides, lipoproteins and smaller molecules are delivered at particle sizes around 20 microns.
A single use disposable device can deliver dry powder mucosal vaccines to lymphoid tissue at the back of the nasal passages. Work has commenced on the feasibility of delivering DNA vaccines by the intranasal route.
The North West Fund for Biomedical is the company’s lead investor.